Company Overview and News

 
Charterprime Launches Custom Livery with AirAsia

2017-05-18 accesswire
KUALA LUMPUR, MALAYSIA / ACCESSWIRE / May 18, 2017 / Charterprime, an international financial services and brokerage group based out of Australia focused on the Asia-Pacific region, has recently launched a custom livery with AirAsia Berhad (MYX: 5099), one of the largest carriers in the region. Charterprime's logo and branding will appear on an AirAsia's Airbus A320-200 aircraft.

 
Anjuli Bhargava: A change of course

2016-04-04 business-standard
Two recent developments at low-cost airline AirAsia India in the last month have taken the aviation industry by surprise. A few weeks ago, the airline announced a brand new management team. And then last week, Tata Sons increased its stake - a second time in a year. As things stand, Tata Sons now owns 49 per cent in the airline, as does Malaysia's AirAsia Berhad. A third partner - after a shaky partnership - has finally exited the venture.

 
KLCI rises 0.51% in line with regional markets

2016-04-04 theedgemarkets
KUALA LUMPUR (April 4): The FBM KLCI rose 0.51% at the midday break today in line with the firmer regional markets.

 
AirAsia up 3.3% on RM1b share placement

2016-04-04 theedgemarkets
KUALA LUMPUR (April 4): AirAsia Bhd gained as much as six sen or 3.3% among the bourse's most-actively traded counters after the budget airline proposed to place out 559 million new shares to major shareholders.

 
KLCI reverses loss, stays above 1,710 support level

2016-04-04 theedgemarkets
KUALA LUMPUR (April 4): The FBM KLCI reversed its loss at mid-morning and stayed above its 1,710 support level.

 
AirAsia flies higher on RM1b share placement

2016-04-04 thestar.com.my
KUALA LUMPUR: Shares of AirAsia Bhd climbed in early Monday trade as investors were positive about the corporate proposal to place out new shares to the founders to raise RM1bil.

 
KLCI to trend sideways, support seen at 1,710

2016-04-03 theedgemarkets
KUALA LUMPUR (April 4): The FBM KLCI is expected to trend sideways today with support seen at the 1,710 point level.

 
Fernandes, Kamarudin to fork out RM1bil cash

2016-04-01 thestar.com.my
Long-time partners: AirAsia says it will issue 559 million new shares in a share placement exercise at RM1.80 a share to Tune Life, owned equally by both Kamarudin (left) and Fernandes.

 
Leong to helm the AirAsia BIG Loyalty Programme

2016-04-01 thestar.com.my
Leong, who was formerly Firefly managing director (2007-2011) is now heading the loyalty programme for AirAsia.

 
GenM, Sumatec, SunCon, AirAsia, Tan Chong, Scomi Engineering and Texchem

2016-04-01 theedgemarkets
KUALA LUMPUR (April 1): Based on corporate announcements and news flow today, companies that may be in focus on Monday (April 4) could include the following: GenM, Sumatec, SunCon, AirAsia and Tan Chong, Scomi Engineering and Texchem.

 
AirAsia to raise $257 mln by selling shares to founders

2016-04-01 livemint
AirAsia proposed to issue 559 million new shares to group chief executive Tony Fernandes and chairman Kamaruddin Meranun

 
Panasonic Malaysia predicts slower FY17 sales growth on weak consumer sentiment

2016-04-01 theedgemarkets
SUBANG (April 1): Japan's Panasonic Malaysia Sdn Bhd expects sales of its consumer electronic products to grow at a slower pace for the current financial year ending March 31, 2017 (FY17), due to weaker consumer sentiment.

 
AirAsia to raise RM1b via share placement with founders

2016-04-01 theedgemarkets
KUALA LUMPUR (April 1): AirAsia Bhd has entered into a share subscription agreement with its founders Tan Sri Tony Fernandes and Datuk Kamarudin Meranun to raise RM1.01 billion.

 
AirAsia to raise RM1b by selling shares to founders

2016-04-01 themalaymailonline
Asia's biggest budget airline proposed to issue 559 million new shares to Group Chief Executive Tony Fernandes and Chairman Kamaruddin Meranun, which will boost their combined stake to 32.4 per cent from 18.9 per cent. — Picture by Yusof Mat Isa KUALA LUMPUR, April 1 — Malaysian budget airline AirAsia Bhd has agreed to raise RM1 billion through a share sale to its founders as part of a strategy to cut debt, one day after Reuters reported the company planned to raise funds.

 
AirAsia said to plan raising over US$200m from share sale to Tune Air

2016-04-01 straitstimes
KUALA LUMPUR (BLOOMBERG) - AirAsia Bhd, the continent's biggest budget airline, is planning to raise more than US$200 million (S$269.7 million) by selling stock to its largest shareholder in a private placement, according to a person familiar with the matter.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...